Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth hormone and cancer: are we asking the right questions?*.

Literature DB >> 16430707

Growth hormone and cancer: are we asking the right questions?*.

Jeff Holly¹, Claire Perks.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2006 PMID： 16430707 DOI： 10.1111/j.1365-2265.2006.02409.x

Source DB: PubMed Journal: Clin Endocrinol (Oxf) ISSN： 0300-0664 Impact factor: 3.478

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope^®): data from the PATRO Adults study.

Authors: Paolo Beck-Peccoz; Charlotte Höybye; Robert D Murray; Suat Simsek; Markus Zabransky; Hichem Zouater; Günter Stalla
Journal: Ther Adv Endocrinol Metab Date: 2020-09-10 Impact factor: 3.565

2. Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.

Authors: Yanrong Qian; Reetobrata Basu; Samuel C Mathes; Nathan A Arnett; Silvana Duran-Ortiz; Kevin R Funk; Alison L Brittain; Prateek Kulkarni; Joseph C Terry; Emily Davis; Jordyn T Singerman; Brooke E Henry; Edward O List; Darlene E Berryman; John J Kopchick
Journal: Cancers (Basel) Date: 2020-12-04 Impact factor: 6.639

2 in total

Growth hormone and cancer: are we asking the right questions?*.

1. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study.

2. Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.

1. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope^®): data from the PATRO Adults study.